[Use of lomustine, teniposide, procarbazine and prednisone (LTPP) in the treatment of terminal-state Hodgkin's disease].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D013713:Teniposide / Q000008:administration & dosage; D013727:Terminal Care
D011344:Procarbazine; D008130:Lomustine; D013713:Teniposide; D011241:Prednisone
Zastosowanie lomustyny, tenipozydu, prokarbazyny i prenizonu (LTPP) w leczeniu końcowego stadium ziarnicy złośliwej.